enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA approves Eli Lilly’s obesity medication for obstructive ...

   www.aol.com/fda-approves-eli-lilly-obesity...

   The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication ...

3. Sleep apnea - Wikipedia

   en.wikipedia.org/wiki/Sleep_apnea

   There is limited evidence for medication, but 2012 AASM guidelines suggested that acetazolamide "may be considered" for the treatment of central sleep apnea; zolpidem and triazolam may also be considered for the treatment of central sleep apnea, [97] but "only if the patient does not have underlying risk factors for respiratory depression".

4. What Is Sleep Apnea? Your Complete Guide - AOL

   www.aol.com/sleep-apnea-complete-guide-115800238...

   Untreated sleep apnea can lead to serious health conditions. Moderate to severe sleep apnea can increase your risk of: High blood pressure. Heart failure. Cardiovascular disease. Stroke. Fatty ...

5. Solriamfetol - Wikipedia

   en.wikipedia.org/wiki/Solriamfetol

   Solriamfetol is used to promote wakefulness in the treatment of excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea in adults. [1] It appears to be more effective in improving excessive daytime sleepiness associated with obstructive sleep apnea than certain other wakefulness-promoting agents including modafinil, armodafinil, and pitolisant.

6. Obstructive sleep apnea - Wikipedia

   en.wikipedia.org/wiki/Obstructive_sleep_apnea

   A recent meta-analysis of 24 epidemiological studies on the prevalence of OSA in the general population aged 18 and older revealed that for ≥ 5 apnea events per hour, OSA prevalence ranged from 9% to 38%, specifically ranging from 13% to 33% in men and 6% to 19% in women, while in the population aged 65 and older, OSA prevalence was as high ...

7. Lilly's weight-loss treatment Zepbound becomes first FDA ...

   www.aol.com/news/lillys-weight-loss-drug-zep...

   Sleep apnea patients stop breathing briefly while sleeping, disturbing the sleep cycle and causing long-term complications such as heart conditions. The condition affects roughly one billion ...

8. Weight-loss drug Zepbound resolves sleep apnea in up to 52% ...

   www.aol.com/news/weight-loss-drug-zepbound...

   Eli Lilly on Friday said its popular weight-loss drug Zepbound helped resolve moderate to severe obstructive sleep apnea in up to 52% of patients in two late-stage trials. U.S.-based Lilly and ...

9. Excessive daytime sleepiness - Wikipedia

   en.wikipedia.org/wiki/Excessive_daytime_sleepiness

   Insufficient quality or quantity of night time sleep [5] Obstructive sleep apnea [6] Misalignments of the body's circadian pacemaker with the environment (e.g., jet lag, shift work, or other circadian rhythm sleep disorders) [7] Another underlying sleep disorder, such as narcolepsy, sleep apnea, [8] idiopathic hypersomnia, or restless legs syndrome